Introduction
The search for asymptomatic bacterial urinary tract colonization (UTC) and its eradication before elective hip and knee arthroplasty surgery is controversial, but reflects widespread practice. The influence of perioperative antibiotic prophylaxis on the dynamics of UTC is unknown.
Objectives
We investigate the role of preoperative urinary tract colonization in patients undergoing elective joint arthroplasty.
Methods
Prospective observational cohort study (November 2011-October 2012) with urine analyses before and 3 days after surgery. Patients with symptomatic infections or long-term urinary catheter carriage were excluded. Postdischarge surveillance included questionnaires to patients and general practitioners at 3 months.
Results 480 asymptomatic patients (370 hip arthroplasties; 297 females; median age 71 y) were enrolled. On admission, 171 patients (35%) had bacterial UTC, mostly due to E. coli. Urine analysis revealed also 169 episodes of leukocyturia. Almost all (95%) received a single-dose perioperative prophylaxis of cefuroxime 1.5 g IV. Median duration of postoperative urinary catheter carriage was 0 days (range, 0-13).
On postoperative day 3, urinary analysis was abnormal in 90 episodes of leukocyturia and 198 episodes of UTC, respectively. Day 3 -bacterial UTC was different from preoperative sampling among 50% of patients and microbiological results revealed a higher proportion of Gram-positive organisms.
Only 30 patients (6%) developed a symptomatic urinary tract infection during a follow-up of 3 months; onethird of pathogens were unrelated to those found during hospitalization. All symptomatic infections were treated with oral antibiotics. There was no seeding of joint prostheses. Estimated minimal laboratory costs for preoperative urinary analyses were € 27,300.
Conclusion
Pre-or postoperative routine urine evaluation of asymptomatic arthroplasty patients is costly and only moderately predicts the pathogen of a potential urinary tract infection. If symptomatic infection occurs, a targeted individualized antibiotic therapy prevents urosepsis and hematogenous spread to joint prosthesis.
